TCL Archive OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations June 6, 1986
TCL Archive House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations August 3, 1979
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
